PRODUCTS SOLD ON PEPTIDESLABIRELAND.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
PRODUCTS SOLD ON PEPTIDESLABIRELAND.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
Tirzepatide has become one of the most studied compounds in metabolic disease research over the past three years, and interest in Ireland has grown significantly alongside global clinical data. For Irish research teams looking to source tirzepatide in Ireland for preclinical or laboratory study, this page provides a full research reference — molecular profile, the published data landscape, quality standards, and Irish supply.
This is a research reference only. Tirzepatide exists as a licensed medicine in several territories (Mounjaro, Zepbound). Research-grade tirzepatide supplied by Peptides Lab Ireland is not a pharmaceutical product — it is supplied exclusively for in-vitro and preclinical laboratory research and must not be used for human administration.
Tirzepatide is a synthetic dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 (glucagon-like peptide-1) receptor. It is a 39-amino acid peptide based on the native GIP sequence, modified to also bind GLP-1R with high affinity. Its molecular formula is C₂₂₅H₃₄₈N₄₈O₆₈, with a molecular weight of approximately 4,813.5 Da. A C20 fatty diacid chain conjugated via a linker to lysine at position 20 extends its half-life to approximately five days, enabling once-weekly dosing in clinical applications.
This dual receptor activity distinguishes tirzepatide mechanistically from pure GLP-1 agonists such as semaglutide, and has generated substantial research interest in the comparative signalling profiles of GIP and GLP-1 pathways.
The primary focus of tirzepatide-related laboratory research is its dual incretin mechanism. Research has examined how simultaneous activation of both GIPR and GLP-1R modifies insulin secretion dynamics, glucagon suppression, beta-cell function, and energy expenditure compared to single-receptor agonism. This comparative mechanistic research is active across European endocrinology departments.
SURMOUNT phase 3 clinical trial data showed tirzepatide achieving greater body weight reductions than any previously approved anti-obesity agent. Preclinical and mechanistic research has since focused on understanding the adipose tissue effects — fat cell lipolysis, adipokine secretion, brown adipose tissue activation — underlying these outcomes.
Tirzepatide has demonstrated significant efficacy in MASH (metabolic dysfunction-associated steatohepatitis) trials. Research teams are actively studying its effects on hepatic lipid accumulation, liver inflammation, and fibrosis pathways in preclinical MASH models.
Tirzepatide’s use in research has helped drive renewed interest in GIP receptor biology itself — a field that was historically understudied relative to GLP-1. Studies examining GIPR expression patterns, its role in fat tissue, and its interaction with GLP-1R signalling have increased substantially since tirzepatide’s clinical emergence.
Peptides Lab Ireland supplies research-grade tirzepatide with the following on every batch:
Dispatched from Ireland with cold-chain packaging and tracked delivery across all Irish addresses.
No. Mounjaro and Zepbound are licensed pharmaceutical products manufactured under GMP conditions for human therapeutic use. Research-grade tirzepatide is manufactured to research purity standards for laboratory study only. It is not a pharmaceutical product and must not be used for human administration.
Research-grade tirzepatide is not a scheduled controlled substance under Irish law and can be legally purchased for in-vitro laboratory research by qualified researchers. See: Are Peptides Legal in Ireland?
Semaglutide is a pure GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 receptor agonist. In research settings, tirzepatide is used to study the combined signalling profile of both incretin receptors, enabling comparative mechanistic work that is not possible with GLP-1 agonists alone.
Yes — tracked, cold-packaged delivery to all Republic of Ireland addresses. Standard delivery 1–3 working days from dispatch.
Research-grade tirzepatide is supplied by Peptides Lab Ireland for in-vitro laboratory and scientific research purposes only. It is not a licensed medicine. It must not be administered to humans or animals. Peptides Lab Ireland operates in compliance with HPRA guidelines. For medical concerns, consult a qualified healthcare professional.
Receive News
